3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia
2
Breast Neoplasms
2
Vomiting
1
Uterine Cervical Neoplasms
1
Trigger Finger Disorder
1
Sarcoma, Alveolar Soft Part
1
Renal Insufficiency
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Pain
1
Neoplasms, Plasma Cell
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nausea
1
Mucositis
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Mast-Cell
1
Leukemia, Hairy Cell
1
Interventions
Dexamethasone
12
Palonosetron
11
Aprepitant
11
Ondansetron
8
Olanzapine
5
Calcium Dobesilate
4
netupitant
2
fosaprepitant
2
Tropisetron
2
Radiotherapy
2
Fluorouracil
2
yangzheng xiaoji
1
rolapitant
1
ramosetron
1
niraparib
1
netupitant, palosentron drug combination
1
nabiximols
1
isatuximab
1
ginger extract
1
dolasetron
1
casopitant
1
Yoga
1
Therapeutics
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Paclitaxel
1
Oxaliplatin
1
Octreotide
1
Midazolam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Nausea
×
Acetaminophen
×
Clear all
NCT01474304
2016-09-29
IVAC
Swedish Medical Center
Phase 2
Unknown
80 enrolled